The DAVA’s 2nd Hawaii Global Summit on Thoracic Malignancies is a five-day meeting comprising seven four-hour sessions with presentations by over 50 key opinion leaders. This summit assembles translational researchers, clinical researchers, and key community oncologists to address and discuss challenges in the rapidly developing area of lung cancer and the evolution of treatment approaches. A session focused on RET lung cancer will discuss new advances and emerging data including new strategies to overcome resistance to current RET therapies. Presentations will be given by experts in the field of lung cancer from leading cancer centers. In addition to this, industry representatives will present their data on emerging studies for RET cancer.
This year the conference will take place at the Fairmont Orchid, Waimea, Hawaii, starting June 27th.
For more information, please visit the Dava Oncology website: